Mymetics Corp (MYMX)

[Work Harder]

2 nd COREVAC meeting

HIV vaccines and mucosal immunity:Results from a phase I trial

Sylvain Fleury,Mymetics, Epalinges,Swiss'confirmed presence

https://translate.google.com/translate?hl=en&sl=fr&u=https://aviesan.fr/fr/content/download/6631/56917/file/programme%2Bcorevac%2Bdu%2B30mai.pdf&prev=search&pto=aue

Participants

Pre-clinical model: Roger Legrand, Armelle Phalipon, Eric Tartour

Clinical trials: Clair Levy-Marchal, Christian Perronne, Odile Launay

Industrial representatives: Sanofi (E Trannoy) Stallergene (Ph Moingeon

2013

Inserm launches a platform for evaluating candidate vaccines against Covid-19 for the performance of large-scale quality trials

https://translate.google.com/translate?hl=en&sl=fr&u=https://presse.inserm.fr/linserm-lance-une-plateforme-devaluation-des-candidats-vaccins-contre-le-covid-19-pour-la-realisation-dessais-de-qualite-a-grande-echelle/40314/&prev=search&pto=aue

CONTACT RESEARCHER

Odile Launay

is launching a platform for the clinical evaluation of candidate vaccines against Covid-19, called COVIREIVAC. It will allow them to be tested rigorously and to obtain solid data on their ability to induce an immune reaction (immunogenicity) as well as on their safety.

under the direction of I-REIVAC coordinator Odile Launay, professor of infectious and tropical diseases at the University of Paris and coordinator of CIC Cochin Pasteur at Cochin hospital (AP -HP), to test vaccines in rigorous clinical trials, which may include several hundred participants.

We can assume she is well aware of Mymx influenza efforts

LOL